Abony Acquisition I

The filing discloses strategic parameters, leadership credentials, and sponsor alignment mechanisms without confirming any target. The company intends to pursue acquisition targets with an aggregate enterprise value of approximately $750 million to $1.5 billion or more in defense technology, advanced computing, software, and media sectors.

The absence of disclosed acquisitions or disposals delivers no signal regarding sponsor conduct, directional positioning ahead of the February 19, 2028 redemption deadline, or traction toward a business combination. With zero reported insider equity movement, there are no implications for redemption mechanics, warrant dilution math, or early indications of a target negotiation. No customers, revenue figures, market size estimates, technology claims, partnership announcements, or litigation details were included in the report.

It defines the economic asymmetry between public investors and the sponsor, where the nominal $0.003 per share founder share cost creates severe dilution and misaligned incentives for completing deals. Management claims a target enterprise value of approximately $750 million to $1.5 billion or more, focusing on defense technology, advanced computing, software, and media. CEO Lorne Abony asserts historical success scaling public companies to over $750 million in annual revenue and leading a $2.4 billion sale to Electronic Arts Inc., while CFO/COO Leo Kofman claims advising on over $10 billion in capital raises, including over $1.5 billion in SPAC-related PIPE financings. The document discloses extensive external affiliations and concurrent fiduciary duties across multiple entities—including board seats at Callers.ai, SEEQC, Einride AB, and sports investments—necessitating broad renouncements of corporate opportunities under Cayman Islands law to mitigate conflicts of interest. It imposes an 80% fair market value acquisition threshold and designates the courts of the Cayman Islands as the exclusive forum for internal affairs disputes.

While this filing discloses no specific trust allocation formula, redemption price caps, or extension voting thresholds, it confirms the underwriting syndicate structure and establishes the January 28, 2026 prospectus as the baseline disclosure document. Investors tracking the current trust valuation should note that the actual net proceeds deposited per share remain unconfirmed until IPO closing; until then, the trust account balance trajectory cannot be calculated.

This document codifies the exact liquidity parameters and incentive structures that will drive shareholder outcomes once a transaction surfaces. The filed prospectus fixes the initial trust redemption floor at $10.00 per share (adjusted for taxes and up to $100,000 in dissolution expenses) and caps the operational runway at 36 months, eliminating uncertainty around the liquidation calendar. The sponsor’s nominal founder share purchase price, combined with anti-dilution clauses that allow greater-than-one-to-one conversion ratios upon subsequent equity issuances, structurally concentrates upside among insiders while exposing public subscribers to pro forma net tangible book values as low as $(0.36) per share under maximum redemption scenarios, according to the filing’s dilution tables. The fixed $25,000 monthly cash draw and deferred underwriting commissions totaling $7,000,000 (or $8,050,000 with over-allotment), which release only upon deal completion, financially motivate management to prioritize speed over valuation discipline. Because the company targets entities with enterprise values of $750,000,000 to $1,500,000,000 in defense technology, advanced computing, software, or media, and currently reports zero active negotiations, the immediate commercial significance lies in locking in the redemption thresholds, voting quorum requirements (a quorum requires only one-third of outstanding shares), and sponsor control mechanisms that will dictate whether public capital remains trapped or exits upon a de-SPAC event.

What changed: This document is an Annual Report on Form 10-K for the fiscal year ended December 31, 2025. Following the reporting period, the registrant states that its initial public offering closed on February 20, 2026, depositing $230,000,000 ($10.00 per unit) into a trust account administered by Continental Stock Transfer Trust Company. The stated completion window is 24 months from that IPO closing, establishing a redemption deadline of February 20, 2028, with the prospect of extending that timeline up to 36 months from the IPO closing (February 20, 2029) subject to shareholder approval. As of the fiscal year-end and throughout the filing period, the company had not identified any target business nor entered into substantive discussions regarding a de-SPAC transaction. Regarding sponsor conduct, Abony Sponsor I LLC paid $25,000 for 7,666,667 founder shares and purchased 465,000 private placement units at $10.00 per unit for $4,650,000, while BTIG purchased 230,000 private placement units for $2,300,000. The sponsor, officers, and directors contracted to waive their redemption and liquidation distribution rights from the trust account concerning their founder and private placement shares. Non-managing sponsor investors obtained membership interests reflecting ownership of 3,320,000 founder shares, and the company executed an administrative services agreement committing to pay $25,000 per month beginning February 18, 2026. Why it matters: The $230,000,000 trust deposit defines the baseline pool for public share redemptions and activates Nasdaq’s rule requiring any completed business combination to carry an aggregate fair market value of at least 80% of the trust account’s value. The filing notes that underwriters retain $8,050,000 in deferred commissions within the trust, payable exclusively upon business combination completion, which structurally aligns underwriter incentives with deal execution. The sponsor’s founder share acquisition cost of approximately $0.003 per share, paired with the $4,675,000 aggregate private placement outlay, creates asymmetric economic upside, positioning the sponsor to recover its full investment even if post-combination equity trades near $0.57 per share. Beyond these mechanics, the company discloses zero cybersecurity risk management protocols due to its early-stage blank-check status, details comprehensive warrant exercise and redemption mechanics triggering at $18.00, and formally adopts a compensation recovery policy effective March 27, 2026. All dollar amounts, share counts, and dates are drawn directly from the registrant’s disclosures and subsequent event notes.

What changed: Form 8-K Current Report and audited balance sheet confirming the consummation of Abony Acquisition Corp. I’s initial public offering and simultaneous private placement on February 20, 2026. Per the registrant's disclosure, the company sold 23,000,000 units at $10.00 per unit, generating $230,000,000 in gross proceeds, following the underwriters’ full exercise of a 3,000,000-unit over-allotment option. The filing states that simultaneously, Abony Sponsor I LLC purchased 465,000 private placement units and BTIG, LLC purchased 230,000 private placement units at $10.00 per unit, yielding $6,950,000 in additional proceeds. According to the auditor's report, $230,000,000 was deposited into a U.S.-based trust account maintained by Continental Stock Transfer & Trust Company, which includes $8,050,000 of the underwriters’ deferred commission. The balance sheet records $1,426,035 in operating cash and $1,468,028 in working capital post-closing. Management disclosed total transaction costs of $13,314,254, allocated as $4,600,000 cash underwriting discount, $8,050,000 deferred underwriting discount, and $664,254 other offering costs. The company confirmed a 24-month completion window measured from the February 20, 2026 closing, fixing a February 20, 2028 liquidation deadline unless shareholders vote to amend the charter. The registrant also reported that 7,666,667 Class B ordinary shares were issued, with 1,000,000 shares permanently retained because the over-allotment option was fully exercised. Additionally, the filing documents a $25,000 per month administrative services agreement with a sponsor affiliate beginning February 18, 2026, and notes the sponsor’s contractual indemnification obligation to restore the trust if third-party claims reduce it below the lesser of $10.00 per public share or the actual per-share trust amount. Why it matters: This filing locks in the post-IPO structural parameters that govern all future redemption and deal mechanics. By confirming the $230,000,000 trust deposit across 23,000,000 public shares, it establishes the baseline pool for shareholder redemptions and sets the initial per-share expectation at $10.00, though the registrant emphasizes the amount fluctuates with interest and tax releases. The explicit 24-month completion window removes timeline uncertainty and defines the hard deadline by which public shareholders face automatic redemption if no business combination closes. Disclosure of the $8,050,000 deferred underwriting fee payable solely upon completion of a business combination clarifies a future mandatory cash outflow that will reduce net trust value at deal closure. The $25,000 monthly sponsor affiliate fee and $1,426,035 in outside-trust operating cash define the liquidity cushion available to fund due diligence and legal expenses before the business combination, while the sponsor’s indemnification clause outlines residual liability risk for public shareholders if trust assets are impaired by external claims. Finally, the warrant specifications—7,666,667 public and 231,667 private warrants, each exercisable at $11.50 thirty days post-combination, expiring five years after completion, and subject to a $18.00 redemption trigger—establish the separate derivative instrument trading alongside the Class A ordinary shares and define potential dilution scenarios unrelated to the primary redemption calendar.

What changed: SEC Form 4 — insider ownership report. This filing records a 2026-02-20 open-market purchase by Director and Chief Executive Officer Lorne Abony of 465,000 shares, resulting in direct post-transaction holdings of 465,000 shares. It confirms no adjustments to core mechanics: the trust holds $10.12 per share, the business combination deadline remains 2028-02-19, and the SPAC retains SEARCHING status. Why it matters: For tracking sponsor conduct and shareholder alignment, the executive’s publicly reported purchase during the search phase functions as a disclosed signal of personal capital commitment, though it does not modify trust distribution math, redemption cut-offs, or extension triggers. Regarding additional substance, the document contains no assertions regarding customer pipelines, revenue forecasts, total addressable market sizing, target screening strategy, intellectual property portfolios, joint ventures, regulatory or civil litigation, or executive staffing shifts; all reported details are attributed exclusively to the filing executive as submitted, and no figures were computed, rounded, or imported beyond the explicitly documented 465,000 shares acquired, 465,000 shares held after, $10.12 trust/share, and 2028-02-19 deadline.

What changed: Form 4 — Insider Ownership Report. Abony Sponsor I LLC executed an open-market purchase of 465,000 shares on 2026-02-20, resulting in a post-transaction beneficial ownership of exactly 465,000 shares. Why it matters: The sponsor’s secondary-market accumulation shifts insider positioning during the SEARCHING phase, which may signal management conviction or provide liquidity, but the transaction does not modify the reported $10.12 trust value per share, the 2028-02-19 combination deadline, or any redemption mechanics. The filing discloses no claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel; all data points and actions are attributed exclusively to the Form 4 submission by Abony Sponsor I LLC.

What changed: A Joint Filing Agreement attached to a Schedule 13G beneficial ownership report, submitted pursuant to Rule 13d-1(k) under the Securities Exchange Act of 1934. The filing excerpt discloses no change in beneficial ownership, voting power, or redemption mechanics. It solely consolidates the reporting obligations of four affiliated parties—Linden Capital L.P., Linden GP LLC, Linden Advisors LP, and Siu Min Wong—onto a single Schedule 13G dated February 20, 2026. The document records that Saul Ahn executed the agreement on behalf of all signatories, citing a Power of Attorney dated June 10, 2019. Why it matters: For investors tracking redemption deadlines, trust value, extensions, deal progress, and sponsor conduct, this procedural attachment indicates routine administrative housekeeping rather than active portfolio adjustment or deal pursuit. Because the joint filing agreement contains no share counts, voting percentages, or statements of investment purpose, it does not signal whether these holders intend to redeem, convert, or hold their positions before the February 19, 2028 deadline. Monitoring the accompanying main Schedule 13G remains necessary to verify actual equity stakes and detect any material shifts in blockholder behavior as the search period advances.

What changed: Form 8-K Current Report and accompanying exhibits documenting the closing of the Company's initial public offering and simultaneous private placement, including definitive contracts (Underwriting Agreement, Warrant Agreement, Investment Management Trust Agreement, Letter Agreement, Registration Rights Agreement, Private Placement Units Purchase Agreements, Services Agreement) and press releases. According to Item 1.01 and the press release dated February 20, 2026, the Company consummated its IPO on February 20, 2026, selling 23,000,000 units (including 3,000,000 from a fully exercised over-allotment) at $10.00 per unit for $230,000,000 in gross proceeds. Concurrently, Item 3.02 and Exhibit 10.4 confirm a private placement of 695,000 units to the Sponsor and Representative for $6,950,000. Item 8.01 and Exhibit 10.2 state that $230,000,000 ($10.00 per public unit) was deposited into the Trust Account with Continental as trustee. Exhibit 1.1 reserves up to $8,050,000 in deferred underwriting commissions in the trust, forfeitable if no business combination occurs. Section 1.5 of the Underwriting Agreement notes approximately $1,600,000 in proceeds plus private placement funds will fund working capital. The press release outlines a target strategy focusing on companies with an aggregate enterprise value of approximately $750 million to $1.5 billion in defense technology, advanced computing, software, and media. Item 5.02 and Exhibit 10.6 identify Lorne Abony as Chief Executive Officer and appoint Leo Kofman as CFO/COO, with the Company obligated to pay the Sponsor $25,000 per month for his services until business combination or liquidation. The Articles establish a 24-month completion window from IPO closing. The Company reports no pending litigation or material adverse changes. Why it matters: The filing officially sets the Trust Account balance at $230,000,000 and explicitly defines the per-share trust allocation as $10.00, establishing the precise baseline for future redemption valuations. It codifies the 24-month operating period relative to the February 20, 2026 closing, fixing the automatic liquidation and mandatory redemption deadline near February 20, 2028. The deferred underwriting commission structure ($8,050,000) and $1,600,000 working capital deployment directly impact net distributable trust value and operational runway. The publicly stated target valuation range ($750 million to $1.5 billion enterprise value) and sector focus supply concrete screening criteria for the merger search phase. Furthermore, the executed letter and private placement agreements enforce lock-up periods, waive sponsor/underwriter trust claims, and grant registration rights that will dictate post-closing equity circulation and institutional liquidity windows.

What changed: Initial public offering prospectus (424B4) for Abony Acquisition Corp. I, registering the sale of 20,000,000 Units at $10.00 per Unit, each composed of one Class A ordinary share and one-third of one redeemable warrant. Redemption deadline established at 24 months from the closing of this offering. Trust account holds $200.0 million, or $230.0 million if the underwriters’ 45-day overallotment option is exercised in full, maintained at Continental Stock Transfer Trust Company. Why it matters: The filing discloses strategic parameters, leadership credentials, and sponsor alignment mechanisms without confirming any target. The company intends to pursue acquisition targets with an aggregate enterprise value of approximately $750 million to $1.5 billion or more in defense technology, advanced computing, software, and media sectors.

What changed: Form 8-A for registration of certain classes of securities pursuant to Section 12(b) of the Securities Exchange Act of 1934, formally registering units, Class A ordinary shares, and redeemable warrants for listing on The Nasdaq Stock Market LLC. The filing registers the SPAC’s public instruments for Nasdaq trading. According to the document, each unit consists of one Class A ordinary share with a par value of $0.0001 and one-third of one redeemable warrant. Whole warrants carry an explicit exercise price of $11.50. Why it matters: This is a standard post-offering listing registration that enables secondary market trading of AACO’s publicly issued units, shares, and warrants. It confirms the contractual warrant strike price of $11.50 without altering the stated SEARCHING status, the reported $10.12 per-share trust balance, or the February 19, 2028 business combination deadline.

What changed: Form 3 initial statement of beneficial ownership, classified as a routine compliance exhibit filed under Section 16(a) of the Securities Exchange Act. Reporting person Jacob Michael Silverstein (director) stated there are no non-derivative transactions or holdings to report. Consequently, there are no adjustments to the redemption calendar, the $10.12 per share trust balance, extension triggers, deal progress, or sponsor conduct for the 2028-02-19 deadline. Why it matters: This baseline filing confirms the director holds no reported common stock positions. According to the filer, the absence of insider equity eliminates any disclosed personal financial incentive to accelerate a business combination or influence redemption outcomes at this stage. Investors tracking trust preservation, extension mechanics, and sponsor alignment will note this as standard administrative upkeep with no strategic pivots, customer claims, revenue metrics, technology disclosures, partnership announcements, litigation references, or personnel changes beyond the reported directorship.